BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15781068)

  • 21. Rat retinal microglial cells under normal conditions, after optic nerve section, and after optic nerve section and intravitreal injection of trophic factors or macrophage inhibitory factor.
    Sobrado-Calvo P; Vidal-Sanz M; Villegas-Pérez MP
    J Comp Neurol; 2007 Apr; 501(6):866-78. PubMed ID: 17311318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of nerve growth factor and TrkA expression in the SVZ of EAE rats: evidence for a possible functional significance.
    Triaca V; Tirassa P; Aloe L
    Exp Neurol; 2005 Jan; 191(1):53-64. PubMed ID: 15589512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Zheng Z; Chen H; Xu X; Li C; Gu Q
    Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
    Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
    Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NGF and Retinitis Pigmentosa: Structural and Molecular Studies.
    Rocco ML; Calzà L; Aloe L
    Adv Exp Med Biol; 2021; 1331():255-263. PubMed ID: 34453304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(-/-) mouse.
    Campbell M; Humphries M; Kennan A; Kenna P; Humphries P; Brankin B
    Exp Eye Res; 2006 Sep; 83(3):484-92. PubMed ID: 16643895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NGF promotes microglial migration through the activation of its high affinity receptor: modulation by TGF-beta.
    De Simone R; Ambrosini E; Carnevale D; Ajmone-Cat MA; Minghetti L
    J Neuroimmunol; 2007 Oct; 190(1-2):53-60. PubMed ID: 17868907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
    Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
    Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of cytokine responses to retinal detachment in rats.
    Nakazawa T; Matsubara A; Noda K; Hisatomi T; She H; Skondra D; Miyahara S; Sobrin L; Thomas KL; Chen DF; Grosskreutz CL; Hafezi-Moghadam A; Miller JW
    Mol Vis; 2006 Aug; 12():867-78. PubMed ID: 16917487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
    Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
    Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nerve growth factor-induced retrograde survival signal mediated by mechanisms downstream of TrkA.
    Mok SA; Campenot RB
    Neuropharmacology; 2007 Feb; 52(2):270-8. PubMed ID: 16949623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo.
    Shi Z; Birman E; Saragovi HU
    Dev Neurobiol; 2007 Jun; 67(7):884-94. PubMed ID: 17506493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder.
    Kikuno N; Kawamoto K; Hirata H; Vejdani K; Kawakami K; Fandel T; Nunes L; Urakami S; Shiina H; Igawa M; Tanagho E; Dahiya R
    BJU Int; 2009 May; 103(10):1424-8. PubMed ID: 18990142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells.
    Raychaudhuri SP; Raychaudhuri SK
    Scand J Rheumatol; 2009; 38(3):207-15. PubMed ID: 19177265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing.
    Micera A; Lambiase A; Puxeddu I; Aloe L; Stampachiacchiere B; Levi-Schaffer F; Bonini S; Bonini S
    Exp Eye Res; 2006 Oct; 83(4):747-57. PubMed ID: 16716299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nerve growth factor acts with the beta2-adrenoceptor to induce spontaneous nociceptive behavior during temporomandibular joint inflammatory hyperalgesia.
    Pelegrini-da-Silva A; Oliveira MC; Parada CA; Tambeli CH
    Life Sci; 2008 Dec; 83(23-24):780-5. PubMed ID: 18930742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nerve growth factor beta/pro-nerve growth factor and their receptors in normal human oral mucosa.
    Hayashi K; Storesund T; Schreurs O; Khuu C; Husvik C; Karatsaidis A; Helgeland K; Martin-Zanca D; Schenck K
    Eur J Oral Sci; 2007 Oct; 115(5):344-54. PubMed ID: 17850422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential activation of dendritic cells by nerve growth factor and brain-derived neurotrophic factor.
    Noga O; Peiser M; Altenähr M; Knieling H; Wanner R; Hanf G; Grosse R; Suttorp N
    Clin Exp Allergy; 2007 Nov; 37(11):1701-8. PubMed ID: 17892512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.